NYXOAH SA (NYXH.BR) Fundamental Analysis & Valuation

EBR:NYXH • BE0974358906

Current stock price

2.65 EUR
-0.19 (-6.69%)
Last:

This NYXH.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NYXH.BR Profitability Analysis

1.1 Basic Checks

  • In the past year NYXH has reported negative net income.
  • NYXH had a negative operating cash flow in the past year.
  • NYXH had negative earnings in each of the past 5 years.
  • NYXH had a negative operating cash flow in each of the past 5 years.
NYXH.BR Yearly Net Income VS EBIT VS OCF VS FCFNYXH.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -89.29%, NYXH is not doing good in the industry: 90.48% of the companies in the same industry are doing better.
  • With a Return On Equity value of -164.01%, NYXH is not doing good in the industry: 84.13% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -89.29%
ROE -164.01%
ROIC N/A
ROA(3y)-31.19%
ROA(5y)-24.1%
ROE(3y)-40.78%
ROE(5y)-30.7%
ROIC(3y)N/A
ROIC(5y)N/A
NYXH.BR Yearly ROA, ROE, ROICNYXH.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • With a decent Gross Margin value of 64.36%, NYXH is doing good in the industry, outperforming 65.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NYXH has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for NYXH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5YN/A
NYXH.BR Yearly Profit, Operating, Gross MarginsNYXH.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NYXH.BR Health Analysis

2.1 Basic Checks

  • NYXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NYXH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NYXH.BR Yearly Shares OutstandingNYXH.BR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NYXH.BR Yearly Total Debt VS Total AssetsNYXH.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • NYXH has an Altman-Z score of -4.95. This is a bad value and indicates that NYXH is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -4.95, NYXH is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
  • NYXH has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • NYXH's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. NYXH outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z -4.95
ROIC/WACCN/A
WACC7.21%
NYXH.BR Yearly LT Debt VS Equity VS FCFNYXH.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that NYXH should not have too much problems paying its short term obligations.
  • NYXH has a Current ratio of 1.70. This is comparable to the rest of the industry: NYXH outperforms 52.38% of its industry peers.
  • NYXH has a Quick Ratio of 1.41. This is a normal value and indicates that NYXH is financially healthy and should not expect problems in meeting its short term obligations.
  • NYXH's Quick ratio of 1.41 is fine compared to the rest of the industry. NYXH outperforms 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.41
NYXH.BR Yearly Current Assets VS Current LiabilitesNYXH.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NYXH.BR Growth Analysis

3.1 Past

  • The earnings per share for NYXH have decreased strongly by -31.24% in the last year.
EPS 1Y (TTM)-31.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%346.87%

3.2 Future

  • NYXH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.80% yearly.
  • The Revenue is expected to grow by 112.36% on average over the next years. This is a very strong growth
EPS Next Y8.66%
EPS Next 2Y14.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year253.2%
Revenue Next 2Y181.36%
Revenue Next 3Y142.13%
Revenue Next 5Y112.36%

3.3 Evolution

NYXH.BR Yearly Revenue VS EstimatesNYXH.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
NYXH.BR Yearly EPS VS EstimatesNYXH.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. NYXH.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NYXH. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NYXH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYXH.BR Price Earnings VS Forward Price EarningsNYXH.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NYXH.BR Per share dataNYXH.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NYXH's earnings are expected to grow with 14.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NYXH.BR Dividend Analysis

5.1 Amount

  • No dividends for NYXH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NYXH.BR Fundamentals: All Metrics, Ratios and Statistics

NYXOAH SA

EBR:NYXH (4/8/2026, 5:29:47 PM)

2.65

-0.19 (-6.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-19
Earnings (Next)05-12
Inst Owners21.79%
Inst Owner ChangeN/A
Ins Owners19.69%
Ins Owner ChangeN/A
Market Cap115.70M
Revenue(TTM)N/A
Net Income(TTM)-83.57M
Analysts81.43
Price Target8.93 (236.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.07%
Min EPS beat(2)-5.02%
Max EPS beat(2)5.16%
EPS beat(4)2
Avg EPS beat(4)-4.98%
Min EPS beat(4)-22.16%
Max EPS beat(4)5.16%
EPS beat(8)5
Avg EPS beat(8)-2.41%
EPS beat(12)6
Avg EPS beat(12)-9.44%
EPS beat(16)9
Avg EPS beat(16)-3.71%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-19.45%
Min Revenue beat(4)-38.43%
Max Revenue beat(4)-1.3%
Revenue beat(8)1
Avg Revenue beat(8)-18.47%
Revenue beat(12)1
Avg Revenue beat(12)-25.3%
Revenue beat(16)1
Avg Revenue beat(16)-32.33%
PT rev (1m)-8.38%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0.23%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)32.3%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)12.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.52
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 136.76
EV/EBITDA N/A
EPS(TTM)-2.36
EYN/A
EPS(NY)-2.16
Fwd EYN/A
FCF(TTM)-1.58
FCFYN/A
OCF(TTM)-1.55
OCFYN/A
SpS0.13
BVpS1.17
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -89.29%
ROE -164.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.36%
FCFM N/A
ROA(3y)-31.19%
ROA(5y)-24.1%
ROE(3y)-40.78%
ROE(5y)-30.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.99%
Cap/Sales 21.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.41
Altman-Z -4.95
F-Score3
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)64.88%
Cap/Depr(5y)74.74%
Cap/Sales(3y)37.33%
Cap/Sales(5y)219.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.57%
EPS Next Y8.66%
EPS Next 2Y14.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%346.87%
Revenue Next Year253.2%
Revenue Next 2Y181.36%
Revenue Next 3Y142.13%
Revenue Next 5Y112.36%
EBIT growth 1Y-59.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-46.75%
EBIT Next 3Y-14.54%
EBIT Next 5Y11.04%
FCF growth 1Y-49.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.83%
OCF growth 3YN/A
OCF growth 5YN/A

NYXOAH SA / NYXH.BR Fundamental Analysis FAQ

What is the fundamental rating for NYXH stock?

ChartMill assigns a fundamental rating of 2 / 10 to NYXH.BR.


What is the valuation status of NYXOAH SA (NYXH.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to NYXOAH SA (NYXH.BR). This can be considered as Overvalued.


What is the profitability of NYXH stock?

NYXOAH SA (NYXH.BR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for NYXH stock?

The Earnings per Share (EPS) of NYXOAH SA (NYXH.BR) is expected to grow by 8.66% in the next year.